Hungary's Richter sees no link between liver damage and Esmya medicine

BUDAPEST (Reuters) - Hungarian drugmaker Richter's clinical data indicate no demonstrable link between liver damage cases and treatment with its uterine fibroid medicine Esmya, the firm said on Monday.